Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8+ T cell immunity. (2022)

First Author: Rosás-Umbert M
Attributed to:  MICA: RIVER - Recent HIV Infection Viral Eradication Research funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41467-022-34171-2

PubMed Identifier: 36309514

Publication URI: http://europepmc.org/abstract/MED/36309514

Type: Journal Article/Review

Volume: 13

Parent Publication: Nature communications

Issue: 1

ISSN: 2041-1723